genfit.com (GNFT) Company Sales Revenue

GENFIT - graphic logo of issuer GNFT

The aggregate sales performance of Genfit S.A. (GNFT) reflects the impact of Iqirvo's commercialization and licensing payments. Revenue growth is supported by the global authority of Genfit S.A. (GNFT) in the therapy of hepatology pathologies. The stability of the trend is maintained by the retention of a leading R&D team. The current level of 0.00 serves as a critical benchmark, allowing investors to assess the fundamental strength of the business and filter out market noise when analyzing earnings.

GNFT Genfit SA Revenue and Sales Volume (07/04/2022 - 12/06/2025)

Comprehensive metric breakdowns and analytics for Genfit Corp (GNFT)

- market price and analyst price targets:
- market capitalization details:
Summary company analysis:Genfit S.A.
Product sample of Genfit SA

Genfit S.A. (GNFT) maintains extensive operations within the biotechnology sector, leveraging R&D and intellectual property. The total sum of all goods and services sold forms the basis for revenue calculations, determining the business's actual turnover. This metric measures fundamental stability, stripping away market noise and the illusory stability of stock quotes. Transparent licensing royalties from Ipsen serve as the key driver for the company in this regard. By analyzing the company's historical sales levels, an investor can determine the extent to which the asset is undervalued.